
Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting
DATE: November 3, 2010
TIME: 8:00 a.m. to 5:00 p.m.
LOCATION: Hilton Washington D.C. North/Gaithersburg, The Ballrooms, 620 Perry Parkway, Gaithersburg, Maryland
CONTACTS: Diem-Kieu Ngo, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, WO31-2417, Silver Spring, MD 20993-0002, 301-796-9001, Fax: 301-847-8533, E-mail: diem.ngo@fda.hhs.gov
The committees will discuss a number of safety concerns with intravenous administration of the anti-seizure drugs phenytoin and fosphenytoin, including the condition known as Purple Glove Syndrome (PGS), and recommend what regulatory actions, if any, are necessary to diminish the risks.
Advisory Committee Calendar > November 3, 2010: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement
No hay comentarios:
Publicar un comentario